Impact of Perioperative Anesthetic Management on Renal Cancer Progression.
Overview
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- M.D. Anderson Cancer Center
- Locations
- 1
- Primary Endpoint
- Postoperative complications
Overview
Brief Summary
The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.
Detailed Description
This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult Participants (18 years of age or older)
- •Participants having radical or partial nephrectomies with curative intent.
Exclusion Criteria
- •Patients with distant metastatic disease and those with multiple (more than 1) primary tumors at the time of the nephrectomy
- •Participants who had radiofrequency or microwave ablations.
Outcomes
Primary Outcomes
Postoperative complications
Time Frame: 72 hours and 30 days postoperatively
Secondary Outcomes
- Overall survival(Recurrence-free survival:The length of time from surgery to last seen without recurrence or with recurrent disease.)